> if monoclonal antibodies such as Regeneron prove ineffective against Omicron, is it still important to provide monoclonals as early treatment in the off chance that the infection could be Delta?
That would be counter-productive if your objective extend the "emergency". ;)
I've been reading that some states have been running low on monoclonal antibody treatment. But maybe it won't matter so much, if they're not as effective.
So I just recently found a magical little tab button that allows me to color in my hyperlinks instead of underlining them. However, I'm realizing the muddled green color I chose isn't too easy to discern from regular bolded words. If there's issues with the color differentiation let me know and I'll try some different color palettes.
> if monoclonal antibodies such as Regeneron prove ineffective against Omicron, is it still important to provide monoclonals as early treatment in the off chance that the infection could be Delta?
That would be counter-productive if your objective extend the "emergency". ;)
I've been reading that some states have been running low on monoclonal antibody treatment. But maybe it won't matter so much, if they're not as effective.
So I just recently found a magical little tab button that allows me to color in my hyperlinks instead of underlining them. However, I'm realizing the muddled green color I chose isn't too easy to discern from regular bolded words. If there's issues with the color differentiation let me know and I'll try some different color palettes.